Follow
Matteo Ferro
Matteo Ferro
European Institute of Oncology
No verified email
Title
Cited by
Cited by
Year
Functional screening identifies miRNAs inducing cardiac regeneration
A Eulalio, M Mano, MD Ferro, L Zentilin, G Sinagra, S Zacchigna, ...
Nature 492 (7429), 376-381, 2012
11152012
Perioperative outcomes of robotic and laparoscopic simple prostatectomy: a European–American Multi-Institutional Analysis
R Autorino, H Zargar, MB Mariano, R Sanchez-Salas, RJ Sotelo, ...
European urology 68 (1), 86-94, 2015
2032015
Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma
G Lucarelli, D Loizzo, R Franzin, S Battaglia, M Ferro, F Cantiello, ...
Expert review of molecular diagnostics 19 (5), 397-407, 2019
1452019
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial …
G Lucarelli, M Rutigliano, F Sallustio, D Ribatti, A Giglio, ML Signorile, ...
Aging (Albany NY) 10 (12), 3957, 2018
1432018
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2–10 ng/ml
M Ferro, D Bruzzese, S Perdona, A Marino, C Mazzarella, G Perruolo, ...
PloS one 8 (7), e67687, 2013
1292013
Outcomes of robot-assisted partial nephrectomy for clinical T2 renal tumors: a multicenter analysis (ROSULA Collaborative Group)
R Bertolo, R Autorino, G Simone, I Derweesh, JD Garisto, A Minervini, ...
European urology 74 (2), 226-232, 2018
1172018
Prognostic value of magnetic resonance phenotype in patients with arrhythmogenic right ventricular cardiomyopathy
GD Aquaro, A De Luca, C Cappelletto, F Raimondi, F Bianco, N Botto, ...
Journal of the American College of Cardiology 75 (22), 2753-2765, 2020
1062020
Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non–muscle-invasive bladder cancer (NMIBC): a systematic review and meta-analysis
MD Vartolomei, D Porav-Hodade, M Ferro, R Mathieu, M Abufaraj, ...
Urologic Oncology: Seminars and Original Investigations 36 (9), 389-399, 2018
1022018
Cisplatin and 5‐fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis
G Di Lorenzo, C Buonerba, P Federico, S Perdonà, M Aieta, P Rescigno, ...
BJU international 110 (11b), E661-E666, 2012
1022012
Phase II study of docetaxel re‐treatment in docetaxel‐pretreated castration‐resistant prostate cancer
G Di Lorenzo, C Buonerba, A Faiella, P Rescigno, M Rizzo, R Autorino, ...
BJU international 107 (2), 234-239, 2011
1022011
The stress hormone norepinephrine increases migration of prostate cancer cells in vitro and in vivo
A Barbieri, S Bimonte, G Palma, A Luciano, D Rea, A Giudice, ...
International journal of oncology 47 (2), 527-534, 2015
922015
Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy
S Perdona, D Bruzzese, M Ferro, R Autorino, A Marino, C Mazzarella, ...
The prostate 73 (3), 227-235, 2013
922013
Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study
G Di Lorenzo, P Federico, C Buonerba, N Longo, G Cartenì, R Autorino, ...
European urology 60 (6), 1280-1284, 2011
922011
Artificial intelligence and machine learning in prostate cancer patient management—current trends and future perspectives
OS Tătaru, MD Vartolomei, JJ Rassweiler, O Virgil, G Lucarelli, F Porpiglia, ...
Diagnostics 11 (2), 354, 2021
912021
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma
G Lucarelli, M Rutigliano, M Ferro, A Giglio, A Intini, F Triggiano, ...
Urologic Oncology: Seminars and Original Investigations 35 (7), 461. e15-461 …, 2017
902017
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer
M Ferro, MD Vartolomei, GI Russo, F Cantiello, ARA Farhan, ...
World journal of urology 37, 507-514, 2019
842019
Salvage stereotactic body radiotherapy for isolated lymph node recurrent prostate cancer: single institution series of 94 consecutive patients and 124 lymph nodes
BA Jereczek-Fossa, G Fanetti, C Fodor, D Ciardo, L Santoro, CM Francia, ...
Clinical Genitourinary Cancer 15 (4), e623-e632, 2017
802017
Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers
M Ferro, D Bruzzese, S Perdonà, C Mazzarella, A Marino, A Sorrentino, ...
Clinica chimica acta 413 (15-16), 1274-1278, 2012
792012
Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis
M Olivieri, M Ferro, S Terreri, M Durso, A Romanelli, C Avitabile, ...
Oncotarget 7 (15), 20636, 2016
782016
Systemic inflammatory markers and oncologic outcomes in patients with high-risk non–muscle-invasive urothelial bladder cancer
F Cantiello, GI Russo, MD Vartolomei, ARA Farhan, D Terracciano, ...
European urology oncology 1 (5), 403-410, 2018
752018
The system can't perform the operation now. Try again later.
Articles 1–20